By  on January 5, 2018


Twenty-seven percent of cosmetic patients at Dr. Amy Wechsler’s Upper East Side office are men — that’s up from just 8 percent in 2014. The sharp rise in male patients is driven largely by Coolsculpting, the fat reduction procedure said to freeze and kill fat cells. Coolsculpting is not new — it first received FDA approval in 2010 — but began gaining traction with men after the publicly traded stock of parent company Zeltiq Aesthetics began gaining attention from Wall Street in 2015, said Laura Dyer, the physician’s assistant who oversees cosmetic procedures at Wechsler’s office. Zeltiq was ultimately acquired by Allergan last year. “Many of these male patients are men in the finance industry who became aware of Zeltiq and Coolsculpting on the stock market,” said Dyer, who noted that the Coolsculpt Mini — a smaller version of the Coolsculpting applicator that can be used on the double chin area and just recently received FDA clearance — is another fast-growing procedure for men. Most notably, Coolsculpting has acted as a gateway for men to discover other noninvasive cosmetic procedures on the market, said Dyer. “They end up coming in for body contouring or to get rid of their double chin and more than 31 percent of them end up converting to ancillary treatments.”

To continue reading this article...

load comments
blog comments powered by Disqus